)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Immuneering
Immuneering (IMRX) investor relations material
Immuneering AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary11 Jun, 2026
Opening remarks and agenda
Meeting called to order at 11:01 A.M. ET on June 11, 2026, with a quorum present and formal agenda outlined.
Board members, executive officers, and representatives from the independent auditor were introduced.
Rules of conduct and voting procedures were explained to participants.
Board and executive committee updates
Election of Peter Feinberg and Laurie B. Keating as Class II directors to serve until the 2029 annual meeting was proposed.
Shareholder proposals
Two proposals presented: election of directors and ratification of the independent auditor for 2026.
Board recommended voting in favor of both proposals.
Identify the CEO and Board Chair roles
Timeline for filing final voting results in 8-K
Max questions allowed per stockholder
Identify the term end for Class II directors
Name the firm ratified as independent auditor
State the deadline for filing the final vote 8-K
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Immuneering
- Atebimetinib plus chemo delivers 17.3 months median OS in first-line pancreatic cancer with strong tolerability.IMRX
Study result1 Jun 2026 - Q1 2026 net loss improved to $13.5M; atebimetinib advanced to Phase 3; cash runway into 2029.IMRXQ1 202615 May 2026
- Vote on director elections and auditor ratification at the June 2026 virtual annual meeting.IMRXProxy filing20 Apr 2026
- Stockholders will vote on director elections and auditor ratification, with strong governance and oversight.IMRXProxy filing20 Apr 2026
- Atebimetinib shows strong survival and tolerability in first-line pancreatic cancer, with phase III underway.IMRX25th Annual Needham Virtual Healthcare Conference13 Apr 2026
- Atebimetinib delivers 64% 12-month survival in First-Line pancreatic cancer with strong tolerability.IMRXLeerink Global Healthcare Conference 20269 Mar 2026
- 64% 12-month survival in pancreatic cancer, $217M cash, Phase 3 trial on track for 2026.IMRXQ4 20256 Mar 2026
- Atebimetinib shows robust survival gains in pancreatic cancer, with Phase III trial launching mid-year.IMRXOppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026
- Deep Cyclic Inhibition MEK inhibitors show strong safety and broad potential, with key data due in 2024.IMRXJefferies 2024 Global Healthcare Conference1 Feb 2026
Next Immuneering earnings date
Q2 20263 Aug, 2026
Immuneering
Next Immuneering earnings date
Q2 20263 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage